Glycine: The Most Abundant Amino Acid You're Not Taking Enough Of

Collagen Synthesis: Why 3g/Day Is Not Enough

Glycine is not just a component of collagen — it is the structural backbone of the entire collagen triple helix. Every third amino acid in every collagen strand is a glycine residue, and this constraint is absolute: without sufficient glycine, collagen synthesis stalls regardless of how much proline, lysine, or vitamin C you consume.

The body synthesizes approximately 3g of glycine per day endogenously, primarily from serine via the enzyme serine hydroxymethyltransferase (SHMT). This sounds adequate until you factor in how many metabolic processes compete for glycine simultaneously: collagen synthesis, creatine production (which consumes ~1g/day), bile acid conjugation, heme synthesis, and glutathione production all draw from the same pool.

Research by Meléndez-Hevia et al. modeled the total glycine demand for full collagen homeostasis and found the body's actual requirement is closer to 10–15g per day. The shortfall between endogenous production (~3g) and true demand creates what some researchers call a state of chronic conditional glycine deficiency — not a clinical deficiency, but a persistent gap that compounds over time.

The Collagen Synthesis Stack

Glycine does not work in isolation. For collagen synthesis, the research-backed co-factors are:

• Glycine (10g) — structural backbone, rate-limiting substrate
• Vitamin C (500mg–1g) — required for prolyl and lysyl hydroxylase enzymes that stabilize the triple helix
• Proline (1–2g) — second most abundant amino acid in collagen, often co-supplemented via gelatin
• Lysine (1–2g) — cross-linking precursor; deficiency impairs tensile strength of new collagen

Timing matters: collagen precursors consumed 30–60 minutes before exercise or connective tissue loading (tendons, ligaments) have shown enhanced delivery to joint tissues in the Shaw et al. 2017 framework, though more RCTs are needed.

Sleep: Glycine as a Hypothalamic Temperature Signal

The sleep benefit of glycine is mechanistically distinct from sedative compounds like GABA agonists or melatonin. Glycine does not cause sedation — it works by accelerating the core body temperature drop that normally signals sleep onset.

Glycine acts as an agonist at glycine receptors (GlyR) in the hypothalamus, specifically in the suprachiasmatic nucleus and areas governing thermoregulation. Activation of these receptors causes peripheral vasodilation — blood vessels in the skin dilate, heat radiates outward, and core body temperature falls. This temperature decline is one of the primary physiological cues the circadian system uses to initiate deep sleep.

The Bannai 2012 RCT

The landmark evidence comes from Bannai et al. (2012), published in Sleep and Biological Rhythms. In this randomized, double-blind, placebo-controlled crossover trial, healthy subjects with self-reported sleep dissatisfaction took 3g of glycine or placebo 1 hour before bed. Key findings:

• Significant reduction in sleep latency (time to fall asleep)
• Improved slow-wave sleep architecture on polysomnography
• Reduced daytime fatigue and sleepiness (measured via Karolinska Sleepiness Scale)
• Improved cognitive performance the following morning
• No next-morning grogginess — a key differentiator from pharmacological sleep aids

A follow-up study (Bannai et al. 2012, Frontiers in Neurology) confirmed the temperature-reduction mechanism via wrist actigraphy and skin temperature monitoring.

GlyNAC: Rebuilding the Master Antioxidant

Glutathione is synthesized in two enzymatic steps from three amino acids: cysteine, glutamate, and glycine. Of these, cysteine and glycine are the rate-limiting precursors — glutamate is rarely deficient. This is why GlyNAC (glycine + N-acetylcysteine) has emerged as a targeted strategy for restoring glutathione in aging populations.

Aging is associated with declining glutathione levels — often 30–50% lower in elderly individuals compared to young adults. This depletion correlates with increased oxidative stress, mitochondrial dysfunction, inflammation, and accelerated tissue aging. Standard antioxidant supplementation (vitamin C, E) does not reliably restore intracellular glutathione, but supplying the direct precursors does.

The Kumar 2022 RCT

The most rigorous human evidence comes from Premranjan Kumar et al. (2022), published in The Journal of Nutrition. This randomized, double-blind, placebo-controlled trial studied elderly adults (71–80 years old) supplemented with GlyNAC for 24 weeks. Results were striking across multiple domains:

The authors noted that elderly subjects showed normalized glutathione levels comparable to young adults by week 24. This is not a marginal effect — it represents a near-complete correction of one of the most reproducible biochemical hallmarks of aging.

Methylation & Cardiovascular: Glycine as a Methyl Buffer

The methylation cycle is one of the most consequential biochemical networks in human physiology, governing DNA methylation, neurotransmitter synthesis, gene expression, and cardiovascular health. Glycine plays a buffer role in this system that is frequently overlooked.

The SAM:SAH Ratio and GNMT

S-adenosylmethionine (SAM) is the universal methyl donor — it donates methyl groups to hundreds of substrates. The ratio of SAM to its demethylated form (SAH, S-adenosylhomocysteine) is a key indicator of methylation capacity. When SAM accumulates excessively, the enzyme glycine N-methyltransferase (GNMT) converts glycine to sarcosine, consuming the excess methyl group and restoring balance.

This makes glycine a genuine methyl group acceptor and methylation buffer — when dietary methyl donors are oversupplied (e.g., excess choline, betaine, or methylfolate), glycine absorbs the surplus and prevents hypermethylation. Adequate glycine availability is therefore important for methylation homeostasis, particularly in individuals supplementing aggressively with methyl donors.

Homocysteine and Cardiovascular Risk

Homocysteine, a toxic intermediate of the methylation cycle, is an established independent risk factor for cardiovascular disease, stroke, and cognitive decline. Glycine supports two pathways that reduce homocysteine:

• Betaine-homocysteine methyltransferase (BHMT): Betaine (trimethylglycine) donates a methyl group to homocysteine, converting it to methionine. This reaction produces dimethylglycine, which is further demethylated to sarcosine and then glycine — completing a cycle that requires glycine availability.
• Transsulfuration pathway: Homocysteine can also be converted to cysteine (and eventually glutathione), a reaction facilitated by adequate glycine supply for downstream glutathione synthesis.

Creatine Synthesis

The body synthesizes creatine from three precursors: glycine, arginine, and methionine. Endogenous creatine synthesis consumes approximately 1–2g of glycine daily, representing one of the largest single demands on the glycine pool. Athletes and individuals under high metabolic demand who supplement creatine externally reduce this drain, effectively sparing glycine for other functions — this is one proposed mechanism behind why creatine and glycine supplementation may be synergistic for sleep and recovery.

Longevity: ITP Data and the Rapamycin Synergy

The NIH Interventions Testing Program (ITP) is the gold standard for pre-clinical longevity research: identical protocols run simultaneously across three independent sites, with rigorous statistical controls. Glycine is one of the handful of compounds that has shown statistically significant lifespan extension under ITP conditions.

ITP Findings

Miller et al. and the ITP consortium found that dietary glycine at ~8% of food by weight extended median lifespan by approximately 4–6% in male and female B6C3F1 mice. Importantly, this extension occurred in both sexes — a higher bar than many interventions that show sex-specific effects. The mechanism is believed to involve:

• Improved collagen maintenance and connective tissue integrity
• Reduction in methionine effective bioavailability (glycine dilutes amino acid ratios, mimicking some effects of methionine restriction)
• Enhanced glutathione synthesis and mitochondrial resilience
• mTORC1 modulation — glycine-driven amino acid sensing may modulate nutrient signaling pathways

Rapamycin + Glycine Synergy

Subsequent ITP cohort analyses have explored interactions between glycine and rapamycin (the mTOR inhibitor with the strongest lifespan data in mice). Some cohorts showed additive effects when both were administered, though the interaction is not fully characterized. The proposed mechanism involves complementary pathways: rapamycin suppresses mTORC1 while glycine supports mitochondrial and tissue maintenance functions that sit downstream of mTOR.

NMDA Receptor Co-Agonism and Cognitive Function

Glycine also functions as an obligatory co-agonist at NMDA glutamate receptors. NMDA receptors require simultaneous binding of both glutamate and a co-agonist (either glycine or D-serine) to activate. This role in synaptic plasticity connects glycine to learning, memory, and cognitive aging. NMDA receptor hypofunction has been implicated in cognitive decline and psychiatric conditions; some researchers have proposed that glycine supplementation could partially restore receptor function in states of relative deficiency.

Evidence Summary

Dosing Protocol

Sleep Protocol

Take 3g of glycine powder dissolved in water 45–60 minutes before bed. The sweet taste makes it easy to take without capsules. No titration required — the Bannai RCT used a flat 3g dose from day one.

Collagen Synthesis Protocol

For tendon, ligament, and skin collagen support: take 10g glycine + 500mg vitamin C + 1–2g proline (or 15g gelatin, which contains all three) 30–60 minutes before connective tissue loading (training, physical therapy). Repeat once more with a meal for a total of ~20g daily.

GlyNAC Protocol

The Kumar 2022 protocol used weight-adjusted dosing (~100mg/kg body weight glycine, ~66mg/kg NAC). For a 75kg adult this approximates 7.5g glycine + 5g NAC daily, split into two doses. This protocol is most relevant for individuals over 60 years old or with documented oxidative stress burden. Start with lower doses (2–3g glycine + 600mg NAC) and titrate up over 2–4 weeks.

Dietary Sources

Glycine is naturally concentrated in collagen-rich foods: bone broth provides ~3–4g per cup, skin-on poultry adds ~1–2g per serving, and gelatin-based foods (aspic, panna cotta made with gelatin) provide 6–8g per serving. These sources supplement, but rarely replace, therapeutic glycine doses from powder.

Safety and Contraindications

Glycine has an excellent safety profile at supplemental doses. Human studies have used doses up to 60g/day without significant adverse effects. The LD50 in rodents is extremely high. Common mild effects at doses above 15g include loose stools, which resolve with dose reduction.

Considerations: Glycine is a co-agonist at NMDA receptors; theoretically, very high doses could interact with NMDA-modulating medications (ketamine, memantine). Individuals with phenylketonuria (PKU) or other aminoacidopathies should consult a physician. Glycine should be used cautiously alongside high-dose methyl donor supplementation until individual response is established.

No known drug interactions have been documented at standard supplemental doses (3–15g/day). Glycine is not scheduled, not a controlled substance, and is classified as GRAS (Generally Recognized as Safe) by the FDA.

Related Protocols